Posted by Michael Wonder on 15 Jan 2020
RFP - supply of diabetes agents: SGLT-2 inhibitors, GLP-1 agonists and DPP-4 inhibitors
15 January 2020 - PHARMAC invites proposals for the supply of diabetes agents: SGLT-2 inhibitors, GLP-1 agonists and DPP-4 inhibitors in New Zealand.
Proposals must be submitted to PHARMAC via the Government Electronic Tenders Service no later than 4 pm NZT Monday 16 March 2020.
